Finance

Lists
Why is B8FK down 2,96%?
Dive Deeper
B8FK:FRA
Biofrontera AG
€2,95
-2,96%
(-0,090) 1D
9 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B8FK...
Open
€2,95
High
€2,95
Low
€2,95
Mkt. cap
17,99 m
Avg. vol.
171,00
Volume
0,00
P/E ratio
3,40
52-wk high
€4,80
52-wk low
€2,18
EPS
€0,87
No. of employees
62
Open
€2,95
High
€2,95
Low
€2,95
Mkt. cap
17,99 m
Avg. vol.
171,00
Volume
0,00
P/E ratio
3,40
52-wk high
€4,80
52-wk low
€2,18
EPS
€0,87
No. of employees
62
News stories
From web sources and news partners
About Biofrontera AG
CEO-
Employees62
Founded1997
Headquarters-
SectorPharmaceutical industry
Websitebiofrontera.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,55 m
-
3,71 m
5,32 m
Cost of goods sold
1,15 m
-
709,00 k
1,01 m
Cost of revenue
1,15 m
-
709,00 k
1,01 m
Research and development expenses
1,20 m
-
539,00 k
601,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,20 m
-
2,46 m
2,26 m
Operating expense
3,40 m
-
3,00 m
2,87 m
Total operating expenses
4,56 m
-
3,70 m
3,87 m
Operating income
-1,00 m
-
9,00 k
1,45 m
Other non operating income
540,00 k
-
38,00 k
37,00 k
EBT including unusual items
-369,00 k
-
41,00 k
1,47 m
EBT excluding unusual items
-369,00 k
-
41,00 k
1,49 m
Income tax expense
1,00 k
-
-
4,00 k
Effective tax rate
-0,27%
-
-
0,27%
Other operating expenses
-
-
-
-
Net income
-370,00 k
-
2,20 m
3,33 m
Net profit margin
-10,41%
-
59,24%
62,60%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
6,00 k
Interest expense
-1,00 k
-
-6,00 k
-
Net interest expenses
-1,00 k
-
-6,00 k
6,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-940,50 k
-
54,75 k
1,56 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme